Divi's Laboratories Limited — Board Meeting, 06-08-2025: Outcome of Board Meeting

Divi's Laboratories has announced a board meeting where it approved the financial results for the quarter ended June 30, 2025. The company delivered solid performance with consolidated total income rising to ₹2,529 Cr, compared to ₹2,197 Cr in the same quarter last year. Consolidated Profit Before Tax (PBT) reached ₹733 Cr, up from ₹604 Cr, while Profit After Tax (PAT) stood at ₹545 Cr, increasing from ₹430 Cr year-on-year. A notable ₹39 Cr forex gain contributed positively this quarter, a turnaround from a ₹1 Cr loss in the prior year. Strong financial results are the key highlight for investors.